Researchers
Stankov, Karmen
Results 61-80 of 239
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2018 | Ursodeoxycholic acid modulates intracellular redox state and sensitizes colon cancer cells to the cytotoxicity induced by epigenetic agent vorinostat | Pavlović, Nebojša   ; Stankov, Karmen ; Stanimirov, Bojan ; Đanić, Maja ; Bogdanović, Gordana ; Goločorbin-Kon, Svetlana ; Mikov, Momir | Conference Paper | Mp. category will be shown later |
| 2017 | The Role of Drug Metabolites in the Inhibition of Cytochrome P450 Enzymes | Mikov, Momir ; Đanić, Maja ; Pavlović, Nebojša ; Stanimirov, Bojan ; Goločorbin Kon, Svetlana ; Stankov, Karmen ; Al-Salami, Hani | Article | 22M22 |
| 2017 | The LRP1 gene polymorphism is associated with increased risk of metabolic syndrome prevalence in the Serbian population | Vučinić, Nataša ; Stokić, Edita ; Đan, Igor ; Obreht, Dragana; Veličković, Nevena ; Stankov, Karmen ; Đan, Mihajla | Article | 23M23 |
| 2017 | Genetic and Epigenetic Drug Targets in Myelodysplastic Syndromes | Stankov, Karmen ; Stankov, Sunčica; Katanić, Jasmina | Article | 21M21 |
| 2017 | Discovery and Validation of Drug Targets Through Human Genetics and Epigenetics | STANKOV, KARMEN | Article | 21M21 |
| 2017 | Ursodeoxycholic acid sensitizes human breast adenocarcinoma cells to doxorubicin-induced apoptosis | STANIMIROV, BOJAN G. ; STANKOV, KARMEN M. ; PAVLOVIĆ, NEBOJŠA M. ; ĐANIĆ, MAJA P. ; VASOVIĆ, VELIBOR M. ; MIKOV, MOMIR M. | Conference Paper | Mp. category will be shown later |
| 2017 | Bile Acid Derivatives as a Promising Metabolic Syndrome Treatment | Mikov, Momir ; Goločorbin Kon, Svetlana ; Pavlović, Nebojša ; Stanimirov, Bojan ; Stankov, Karmen ; Rašković, Aleksandar ; Al Salami, Hani | Conference Paper | Mp. category will be shown later |
| 2017 | Antioxidant effects of ursodeoxycholic acid in doxorubicin-induced oxidative hepatocyte injury | STANIMIROV, BOJAN G. ; STANKOV, KARMEN M. ; PAVLOVIĆ, NEBOJŠA M. ; ĐANIĆ, MAJA P. ; GOLOČORBIN KON, SVETLANA S. ; VASOVIĆ, VELIBOR M. ; MIKOV, MOMIR M. | Conference Paper | Mp. category will be shown later |
| 2017 | Nova perspektiva tretmana dijabetes mellitusa: mesto žučnih kiselina, probiotika i gliklazida kao mogući tretman dijabetesa tip 1 | MIKOV, MOMIR M. ; ĐANIĆ, MAJA P. ; PAVLOVIĆ, NEBOJŠA M. ; STANIMIROV, BOJAN G. ; STANKOV, KARMEN M. ; H. Al Salami | Conference Paper | Mp. category will be shown later |
| 2016 | Targeting endoplasmic reticulum stress in diabetes | Stanimirov, Bojan ; Stankov, Karmen ; Pavlović, Nebojša ; Stojančević, Maja ; Goločorbin-Kon, Svetlana ; Mikov, Momir | Conference Paper | Mp. category will be shown later |
| 2016 | Cytotoxic Activities and Pharmacological Interactions of Natural Bile Acids with Doxorubicin in Human Breast Adenocarcinoma Cell Line | Stanimirov, Bojan ; Stankov, Karmen ; Pavlović, Nebojša ; Đanic, Maja ; Kojić, Vesna ; Bogdanović, Gordana ; Mikov, Momir | Conference Paper | Mp. category will be shown later |
| 2016 | May bile acids be utilized to enrich oncological armamentarium? | Stanimirov, Bojan ; Pavlović, Nebojša ; Stankov, Karmen ; Stojančević, Maja ; Goločorbin-Kon, Svetlana ; Kojić, Vesna V. ; Mikov, Momir | Conference Paper | Mp. category will be shown later |
| 2016 | In silico pristup u pronalasku analoga karnozola sa poboljšanim farmakokinetskim osobinama | Pavlović, Nebojša ; Đanić, Maja ; Stanimirov, Bojan ; Lalić-Popović, Mladena ; Stankov, Karmen ; Goločorbin-Kon, Svetlana ; Mikov, Momir | Conference Paper | Mp. category will be shown later |
| 2016 | Hypocholesterolaemic effects of probiotics | Đanić, Maja ; Pavlović, Nebojša ; Stanimirov, Bojan ; Stankov, Karmen ; Goločorbin-Kon, Svetlana ; Mikov, Momir | Conference Paper | Mp. category will be shown later |
| 2016 | In vitro model for the analysis of 12-monoketocholate impact on simvastatin physico-chemical behavior in octanol/buffer system | ĐANIĆ, MAJA ; PAVLOVIĆ, NEBOJŠA ; LALIĆ POPOVIĆ, MLADENA ; STANIMIROV, BOJAN ; GOLOČORBIN KON, SVETLANA ; STANKOV, KARMEN ; Mikov, Momir | Conference Paper | Mp. category will be shown later |
| 2016 | In silico modeli kao alternativa za životinjske in vivo sisteme u procesu razvoja lekova | Pavlović, Nebojša ; Goločorbin-Kon, Svetlana ; Stankov, Karmen ; Đanić, Maja ; Stanimirov, Bojan ; Lalić-Popović, Mladena ; Mikov, Momir | Conference Paper | Mp. category will be shown later |
| 2016 | Uloga kliničke farmakologije u personalizovanoj medicini | Vasović, Velibor ; Goločorbin-Kon, Svetlana ; Mikov, Momir ; Stankov, Karmen | Conference Paper | Mp. category will be shown later |
| 2016 | In silico pristup u pronalasku analoga karnozola sa poboljšanim - farmakokinetskim osobinama | Pavlović, Nebojša ; Stojančević, Maja ; Goločorbin-Kon, Svetlana ; Stanimirov, Bojan ; Lalić-Popović, Mladena ; Stankov, Karmen ; Mikov, Momir | Conference Paper | Mp. category will be shown later |
| 2016 | Ursodeoxycholic acid potentiates cytotoxic activity and pro-apoptotic potential of doxorubicin in breast adenocarcinoma cells | Stanimirov, Bojan ; Stankov, Karmen ; Pavlović, Nebojša ; Đanić, Maja ; Mikov, Momir | Conference Paper | Mp. category will be shown later |
| 2016 | Crevni mikrobiom – nova meta personalizovane medicine | Stojančević, Maja ; Pavlović, Nebojša ; Stanimirov, Bojan ; Goločorbin-Kon, Svetlana ; Stankov, Karmen ; Mikov, Momir | Conference Paper | Mp. category will be shown later |